These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9876956)

  • 1. Clinical trial designs for demonstrating disease-course-altering effects in dementia.
    Whitehouse PJ; Kittner B; Roessner M; Rossor M; Sano M; Thal L; Winblad B
    Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):281-94. PubMed ID: 9876956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome measures in clinical trials on medicinal products for the treatment of dementia: a European regulatory perspective.
    Broich K
    Int Psychogeriatr; 2007 Jun; 19(3):509-24. PubMed ID: 17433121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
    Bodick N; Forette F; Hadler D; Harvey RJ; Leber P; McKeith IG; Riekkinen PJ; Rossor MN; Scheltens P; Shimohama S; Spiegel R; Tanaka S; Thal LJ; Urata Y; Whitehouse P; Wilcock G
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():50-3. PubMed ID: 9305517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Post SG; Beerman B; Brodaty H; Gaines AW; Gauthier SG; Geldmacher DS; Hill S; Homma A; Rossor MN; Whitehouse PJ; Winblad B
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():26-8. PubMed ID: 9305511
    [No Abstract]   [Full Text] [Related]  

  • 6. Report of the European Working Group on Dementia Drug Guidelines Meeting--Brussels, November 1997.
    Harvey RJ; Whitehouse PJ; Rossor MN
    Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):259-61. PubMed ID: 9876953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Gauthier S; Bodick N; Erzigkeit E; Feldman H; Geldmacher DS; Huff J; Mohs R; Orgogozo JM; Rogers S
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507
    [No Abstract]   [Full Text] [Related]  

  • 8. Harmony and consensus: cultural aspects of organization in international science.
    Gaines AD; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):295-301. PubMed ID: 9876957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Feldman H; Anand R; Blesa R; Dubois B; Gray J; Homma A; Mohr E; Morris JC; Parys W; Raschig A; Robillard A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520
    [No Abstract]   [Full Text] [Related]  

  • 10. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Ferris SH; Lucca U; Mohs R; Dubois B; Wesnes K; Erzigkeit H; Geldmacher D; Bodick N
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():34-8. PubMed ID: 9305514
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment.
    van Reekum R; Simard M; Farcnik K
    Can Fam Physician; 1999 Apr; 45():945-52. PubMed ID: 10216793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacologic treatment of Alzheimer's disease: a guide for the general psychiatrist.
    Flint AJ; van Reekum R
    Can J Psychiatry; 1998 Sep; 43(7):689-97. PubMed ID: 9773218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.
    Molnar FJ; Man-Son-Hing M; Fergusson D
    J Am Geriatr Soc; 2009 Mar; 57(3):536-46. PubMed ID: 19187414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials.
    Rother M; Erkinjuntti T; Roessner M; Kittner B; Marcusson J; Karlsson I
    Dement Geriatr Cogn Disord; 1998 Jul; 9 Suppl 1():36-43. PubMed ID: 9716243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines.
    Doody R; Whitehouse PJ; Chen Q; Wang L; Wu Q; Rosser M; Xu XH
    Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):263-5. PubMed ID: 9876954
    [No Abstract]   [Full Text] [Related]  

  • 16. Cognitive pharmacotherapy of Alzheimer's disease and other dementias.
    Herrmann N
    Can J Psychiatry; 2002 Oct; 47(8):715-22. PubMed ID: 12420649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
    Harvey RJ; Sciulli CG; Mason RM; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():29-32. PubMed ID: 9305512
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T; Hommet C; Camus V
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future.
    Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():2-5. PubMed ID: 9305506
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.